Has COVID-19 changed the approach to HIV diagnosis?: A multicentric Italian experience.


Journal

Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R

Informations de publication

Date de publication:
15 Oct 2021
Historique:
received: 26 03 2021
accepted: 14 09 2021
entrez: 3 11 2021
pubmed: 4 11 2021
medline: 16 11 2021
Statut: ppublish

Résumé

The occurrence of COVID-19 pandemic had a significant negative effect on health care systems over the last year. Health care providers were forced to focus mainly on COVID-19 patients, neglecting in many cases equally important diseases, both acute and chronic. Therefore, also screening and diagnostic strategies for HIV could have been significantly impaired.This retrospective, multicenter, observational study aimed at assessing the number and characteristics of new HIV/AIDS diagnoses during COVID-19 pandemic in Italy and compared characteristics of people living with HIV at diagnosis between pre- and post-COVID-19 era (2019 vs 2020).Our results showed a significant reduction of HIV diagnoses during pandemic. By contrast, people living with HIV during pandemic were older and were diagnosed in earlier stage of disease (considering CD4+ T cell count) compared to those who were diagnosed the year before. Moreover, there was a significant decrease of new HIV diagnoses among men who have sex with men, probably for the impact of social distancing and restriction applied by the Italian Government. Late presentation incidence, if numbers in 2020 were lower than those in 2019, is still an issue.Routinely performing HIV testing in patients with suspected SARS-CoV-2 infection is identifying and linking to care underdiagnosed people living with HIV earlier. Thus, combined tests (HIV and SARS-CoV-2) should be implemented in patients with SARS-CoV-2 symptoms overlapping HIV's ones. Lastly, our results lastly showed how urgent implementation of a national policy for HIV screening is necessary.

Identifiants

pubmed: 34731116
doi: 10.1097/MD.0000000000027418
pii: 00005792-202110150-00016
pmc: PMC8519218
doi:

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e27418

Subventions

Organisme : None
ID : no

Informations de copyright

Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Déclaration de conflit d'intérêts

The authors report no conflicts of interest.

Références

Power L. COVID-19 has had a major impact on PrEP, sexual behavior and service provision, 9 July 2020; Available at: https://www.aidsmap.com/news/jul-2020/covid-19-has-had-major-impact-prep-sexual-behaviour-and-service-provision . Accessed February 26, 2021.
Ciccullo A, Baldin G, Capetti A, et al. Cohort profile: The Observational cohort for the study of DOlutegravir in Antiretroviral Combination REgimens (ODOACRE). BMJ Open 2019;9:e029960.
Antinori A, Coenen T, Costagliola D, et al. Late presentation of HIV infection: a consensus definition. HIV Med 2011;12:61–4.
Giamello JD, Abram S, Bernardi S, Lauria G. The emergency department in the COVID-19 era. Who are we missing? Eur J Emerg Med 2020;27:305–6.
Pampati S, Emrick K, Siegler AJ, et al. Changes in sexual behavior, PrEP adherence, and access to sexual health services due to the COVID-19 pandemic among a cohort of PrEP-using MSM in the South. JAIDS 2020.
Van Den Bogaart L, Ranzani A, Oreni L, et al. Overlooked cases of HIV infection: An Italian tale of missed diagnostic opportunities. Eur J Intern Med 2020;73:30–5.
European Centre for Prevention and Control. HIV/AIDS Surveillance in Europe 2020, 2019 data, 26 November 2020, Available at: https://www.ecdc.europa.eu/sites/default/files/documents/hiv-surveillance-report-2020.pdf . Accessed February 26, 2021.
Infectious Diseases Society of America. Routine HIV Screenings Decreased, Patients with Acute HIV Infections Increased In Chicago ERs During COVID. 23 October 2020, Available at: https://www.idsociety.org/news--publications-new/articles/2020/routine-hiv-screenings-decreased-patients-with-acute-hiv-infections-increased-in-chicago-ers-during-covid/ . Accessed February 26, 2021.
Antiretroviral Therapy Cohort Collaboration. Importance of baseline prognostic factors with increasing time since initiation of highly active antiretroviral therapy collaborative analysis of cohort of HIV-1-infected patients. Epidemiol Soc Sc 2007;46:607–15.
Raffetti E, Postorino MC, Castelli F, et al. The risk of late or advanced presentation of HIV infected patients is till high, associated factors evolve but impact on overall mortality is vanishing over calendar year: results from the Italia MASTER Cohort. BMC Pub Health 2016;16:878–98.
Tan SS, Chew KL, Saw S, Jureer R, Sethi S. Cross-reactivity of SARS-CoV-2 with HIV chemiluminescent assay leading to false-positive results. J Clin Path 2020;74:614.

Auteurs

Maria Mazzitelli (M)

Infectious and Tropical Diseases Unit, Department of Medical and Surgical Sciences, "Magna Graecia" University of Catanzaro, Catanzaro, Italy.

Arturo Ciccullo (A)

Gemelli Molise Hospital, Campobasso, Italy.

Gianmaria Baldin (G)

Mater Olbia Hospital, Olbia, Italy.

Roberto Cauda (R)

Catholic University of the Sacred Heart, Rome, Italy.
Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS, Rome, Italy.

Stefano Rusconi (S)

III Infectious Diseases Unit, ASST FBF-Sacco, Milan, Italy.
UOC Malattie Infettive, Ospedale di Legnano, ASST Ovest Milanese, Italy.

Andrea Giacomelli (A)

III Infectious Diseases Unit, ASST FBF-Sacco, Milan, Italy.
DIBIC Luigi Sacco, Università degli Studi di Milano, Milan, Italy.

Letizia Oreni (L)

III Infectious Diseases Unit, ASST FBF-Sacco, Milan, Italy.
DIBIC Luigi Sacco, Università degli Studi di Milano, Milan, Italy.

Vanni Borghi (V)

Clinica Malattia Infettive, Università di Modena e Reggio Emilia.

Cristina Mussini (C)

Clinica Malattia Infettive, Università di Modena e Reggio Emilia.

Giovanni Guaraldi (G)

Clinica Malattia Infettive, Università di Modena e Reggio Emilia.

Gaetana Sterrantino (G)

Dipartimento di Medicina clinica e Sperimentale presso l'Università degli studi di Firenze.

Filippo Lagi (F)

Dipartimento di Medicina clinica e Sperimentale presso l'Università degli studi di Firenze.

Bianca Candelaresi (B)

Clinica Malattie Infettive, Azienda Ospedaliero-Universitaria Ospedali Riuniti di Ancona, Ancona, Italy.

Oscar Cirioni (O)

Clinica Malattie Infettive, Azienda Ospedaliero-Universitaria Ospedali Riuniti di Ancona, Ancona, Italy.

Andrea De Vito (A)

Unit of Infectious Diseases, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.

Barbara Rossetti (B)

UOC Malattie Infettive e Tropicali, Azienda Ospedaliero-Universitaria Senese, Siena, Italy.

Carlo Torti (C)

Infectious and Tropical Diseases Unit, Department of Medical and Surgical Sciences, "Magna Graecia" University of Catanzaro, Catanzaro, Italy.

Simona Di Giambenedetto (S)

Catholic University of the Sacred Heart, Rome, Italy.
Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH